MedTrace Logo

SpinePal Open Pilot

NCT07737912 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2026-07-31

No results posted yet for this study

Summary

SpinePal is a self-guided digital intervention developed for patients undergoing spine surgery. The goal of this study is to learn if SpinePal is acceptable to people undergoing spine surgery. The main questions the investigators aim to answer are:

* Is the SpinePal platform considered usable and acceptable by people undergoing spine surgery?
* Is the SpinePal intervention feasible among people undergoing spine surgery?

Participants will:

* Take a screening questionnaire
* Engage with SpinePal for about 2 weeks before surgery and 4 weeks after surgery
* Wear a smartwatch
* Complete questionnaires about 4 weeks after surgery
* Complete a brief virtual interview to share feedback with the study team

Conditions

  • Spine Surgery

Interventions

DEVICE

SpinePal

SpinePal is a web-based app designed to support patients undergoing spine surgery. The app includes tailored pain education, cognitive-behavioral skills, mindfulness and relaxation activities, and guided imagery exercises. SpinePal was developed through an iterative refinement process with patients who previously underwent surgery and experienced persistent pain, impairment, and opioid use.

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • Trustees of Dartmouth College

    lead OTHER

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-01
Primary Completion
2026-12-01
Completion
2026-12-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07737912 on ClinicalTrials.gov